PTPRO and acute myeloid leukemia: Interesting, another cohort (GSE12417-GPL570), which include 79 AML samples, showed high PTPRO expression were associated with better prognosis (OS HR = 0.10, 95% CI= 0.02 to 0.59, Cox P = 0.01).